Laura Jéssica Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Laura Jéssica Pereira has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Emmilly de Oliveira Alves
Laboratório de Desenvolvimento Farmacotécnico, Universidade Federal de São João del-Rei, Campus Centro-Oeste “Dona Lindu”, Minas Gerais, Brazil
2 shared publications - Kátia Regina Ribeiro
Laboratório de Desenvolvimento Farmacotécnico, Universidade Federal de São João del-Rei, Campus Centro-Oeste “Dona Lindu”, Minas Gerais, Brazil
2 shared publications - Mairon César Coimbra
Campus Centro-Oeste Dona Lindu, Universidade Federal de São João Del-Rei (UFSJ), Divinópolis 35501-296, MG, Brazil
2 shared publications - Renê Oliveira Do Couto
Federal University of São João Del-Rei, Brazil
2 shared publications - Rúbia Bellard e Silva
Laboratório de Desenvolvimento Farmacotécnico, Universidade Federal de São João del-Rei, Campus Centro-Oeste “Dona Lindu”, Minas Gerais, Brazil
2 shared publications - André Luis Lacerda Bachi
Post-Graduation Program in Health Sciences, Santo Amaro University (UNISA), São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 6 February 2026
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 36 (1) , 28
Alternative Model-Based Safety Assessment of a Celtis iguanaea Standardized Spray-Dried Extract
The Celtis iguanaea (Jacq.) Sarg., Cannabaceae, standardized spray-dried extract, underwent acute safety evaluation using a range of alternative toxicological models in alignment with Organization for Economic Co-operation and Development Test Guidelines. Acute aquatic toxicity was assessed using the Artemia salina lethality test (LC 50 418.4 μg/ml) and the zebrafish ( Danio rerio ) embryo toxicity test (OECD TG 236; LC 50 1116.0 μg/ml). According to the Globally Harmonized System aquatic toxicity categories, C. iguanaea spray-dried extract is classified as non-hazardous (LC 50 > 100 μg/ml). In vitro assays included cytotoxicity (methyl thiazolyl tetrazolium assay –in WI-38 and HaCaT cells; resazurin in Caco-2 and HT-29 cells), cell adhesion genotoxicity (comet assay; OECD TG 489), and mutagenicity (cytokinesis-block micronucleus assay; OECD TG 487). Celtis iguanaea spray-dried extract showed no cytotoxic, genotoxic, or mutagenic effects up to 250 μg/ml and enhanced HaCaT cell viability and adhesion at higher concentrations (100 μg/ml), suggesting potential support for wound healing. No antimicrobial activity was observed against Candida spp., ESKAPE pathogens, or bacteria associated with urinary tract infections (MIC > 1024.0 μg/ml). This weight-of-evidence assessment supports the safe use of C. iguanaea spray-dried extract in topical or oral formulations and provides data suitable for regulatory hazard characterization and acute risk assessment. Graphical Abstract
- 6 February 2026
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 36 (1) , 28
Open AccessAlternative Model-Based Safety Assessment of a Celtis iguanaea Standardized Spray-Dried Extract
The Celtis iguanaea (Jacq.) Sarg., Cannabaceae, standardized spray-dried extract, underwent acute safety evaluation using a range of alternative toxicological models in alignment with Organization for Economic Co-operation and Development Test Guidelines. Acute aquatic toxicity was assessed using the Artemia salina lethality test (LC 50 418.4 μg/ml) and the zebrafish ( Danio rerio ) embryo toxicity test (OECD TG 236; LC 50 1116.0 μg/ml). According to the Globally Harmonized System aquatic toxicity categories, C. iguanaea spray-dried extract is classified as non-hazardous (LC 50 > 100 μg/ml). In vitro assays included cytotoxicity (methyl thiazolyl tetrazolium assay –in WI-38 and HaCaT cells; resazurin in Caco-2 and HT-29 cells), cell adhesion genotoxicity (comet assay; OECD TG 489), and mutagenicity (cytokinesis-block micronucleus assay; OECD TG 487). Celtis iguanaea spray-dried extract showed no cytotoxic, genotoxic, or mutagenic effects up to 250 μg/ml and enhanced HaCaT cell viability and adhesion at higher concentrations (100 μg/ml), suggesting potential support for wound healing. No antimicrobial activity was observed against Candida spp., ESKAPE pathogens, or bacteria associated with urinary tract infections (MIC > 1024.0 μg/ml). This weight-of-evidence assessment supports the safe use of C. iguanaea spray-dried extract in topical or oral formulations and provides data suitable for regulatory hazard characterization and acute risk assessment. Graphical Abstract
- 11 August 2025
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 35 (6) , 1209-1230
Quality-by-design Development of Celtis iguanaea Microparticles with In vivo Gastroprotective Efficacy
- 11 August 2025
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 35 (6) , 1209-1230
Quality-by-design Development of Celtis iguanaea Microparticles with In vivo Gastroprotective Efficacy